Business
Vistin Pharma ASA: Invitation to Q3 2025 conference call
Oslo, Norway, 24 October 2025 Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on Friday 31st of October 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The third quarter conference call will be available via web and audio through the following access points: Webcast: https://edge.media
About this update from Vistin Pharma Asa
[{"type":"image","alt":"Vistin Pharma ASA","displaySize":"","headline":null,"caption":"Vistin Pharma ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":140,"url":"https://media.zenfs.com/en/globenewswire.com/ac8aa8cffa4cdd54adc69f5141a335bf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NkKrHG5t6cerGaG2Lk6dkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ac8aa8cffa4cdd54adc69f5141a335bf","width":300,"height":140}},"lazy":false},{"type":"text","content":"Oslo, Norway, 24 October 2025","length":29,"tagName":"p"},{"type":"text","content":"Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on Friday 31st of October 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion.","length":294,"tagName":"p"},{"type":"text","content":"The conference call will be held in English.","length":44,"tagName":"p"},{"type":"text","content":"The third quarter conference call will be available via web and audio through the following access points:","length":106,"tagName":"p"},{"type":"text","content":"Webcast: https://edge.media-server.com/mmc/p/zojifvb6","length":53,"tagName":"p"},{"type":"text","content":"Telephone conference (online registration): https://register-conf.media-server.com/register/BI4b6411bcd117427f8df81e59f7b2fd65","length":127,"tagName":"p"},{"type":"text","content":"*****","length":5,"tagName":"p"},{"type":"text","content":"For further information, please contact:","length":40,"tagName":"p"},{"type":"text","content":"Alexander KarlsenCFO+47 [email protected]","length":63,"tagName":"p"},{"type":"text","content":"About Vistin Pharma | www.vistin.com","length":36,"tagName":"p"},{"type":"text","content":"Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.","length":434,"tagName":"p"},{"type":"text","content":"","length...